Key Record Dates Identifier: NCT00531115
Brief Title: Phase II Study to Evaluate Safety and Efficacy of Cetuximab in Combination With XELOX for 12 Weeks Followed by Maintenance Treatment With Cetuximab Plus Capecitabine as First-line Treatment in Elderly Patients With Metastatic Colorectal Cancer.

First Submitted : September 17, 2007
First Submitted that Met QC Criteria : September 17, 2007
First Posted : September 18, 2007 (Estimate)

Last Update Submitted that Met QC Criteria : February 19, 2013
Last Update Posted : February 20, 2013 (Estimate)